Filters

ARF4 Antibody

ARF4 Antibody size: 0.1mg 406

Supplier NJS POLY
Price 406
Size 0.1mg
CategoryAntibody
Concentration pH7, with 0, 02% sodium azide, 3, 5 mg/ml in 1X TBS, 5% BSA (US sourced) and 0
FormAntigen affinity purified
ConjugationUnconjugated
ClonePolyclonal antibody
Recognised antigenARF4
Host animalGoat (Capra aegagrus hircus)
ClonalityPolyclonal (goat origin)
Species reactivity Due to limited knowledge and inability to test the antibody against all known species, Mouse (Mus musculus) , we cannot guarantee that no other cross reactivity can occur, Human (Homo sapiens)
Tested applications ELISA (peptide), WB
Recommended dilutions3-1ug/ml, ELISA (peptide) LOD: 1:128000, Western blot: 0
NotesOptimal dilution of the ARF4 antibody should be determined by the researcher
Intented useThis ARF4 antibodyis to be used only for research purposes and not for diagnostics
Gene ID #378
PurityAntigen affinity
DescriptionAdditional name(s) for this target protein: ADP-ribosylation factor 4
ImmunogenAmino acids SEMTDKLGLQSLRN were used as the immunogen for this ARF4 antibody
Storage Celcius or lower, Cycles of freezing and thawing can denaturate the peptide chains of the antibodies and reduce their sensitivity and/or change their affinity, Prepare aliqotes in such a manner so that freeze-thaw cycles are minimized, Aliquot and store the ARF4 antibody at -20 deg
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by NJS poly they should be stored frozen at - 24°
Gene targetARF4
Short nameARF4 Antibody
Technique antibodies against human proteins, antibodies for, Antibody
Alternative nameARF4 (Antibody to)
Alternative techniqueantibodies
Identity 655
Gene ARF4
Long gene name ADP ribosylation factor 4
Synonyms gene ARF2
Synonyms gene name ADP-ribosylation factor 2
Locus 3p14, 3
Discovery year 1992-07-09
GenBank acession M36341
Entrez gene record 378
Pubmed identfication 2107548
RefSeq identity NM_001660
Classification ARF GTPase family
Havana BLAST/BLAT OTTHUMG00000158601

Subscribe to our Newsletter